US News & World Report - July 28, 2020
Philip Ozuah, M.D., Ph.D., urges health care leaders and institutions to work with community-based organizations and public officials to combat the social determinants of health and related inequities, such as poverty, unemployment, and substandard housing, that leave minorities and people of lower income at increased risk of contracting COVID-19. Dr. Ozuah is president and CEO of Montefiore Medicine.
Additional coverage includes The New York Times, MSNBC
Dr. Ozuah's ProfileMore coverage on Dr. Ozuah
WebMD - July 27, 2020
Oladimeji Oki, M.D., discusses the social, economic, and quality-of-life factors that may account for higher rates of COVID-19 cases and mortality among Hispanics. Dr. Oki is assistant professor of family and social medicine at Einstein and a family medicine physician at Montefiore Health System.
Dr. Oki's Profile
Science News - July 23, 2020
Marla Keller, M.D., Will Southern, M.D., M.S., and Shitij Arora, M.D., are co-authors on a study that finds a blood test can help physicians determine which hospitalized patients with COVID-19 can benefit from steroids. Dr. Keller is vice chair of research in the department of medicine; Dr. Southern is chief of hospital medicine; and Dr. Arora is associate professor of medicine and a hospitalist at Montefiore.
Additional coverage includes USA Today, LoHud, Fox News, US News & World Report (via HealthDay), Daily Mail, LabPulse
Dr. Keller's Profile
WSJ - July 14, 2020
Nir Barzilai, M.D., says varying rates of protein level changes are among the biological differences in how men and women age. Dr. Barzilai is the Ingeborg and Ira Leon Rennert Chair of Aging Research and director of the Institute for Aging Research at Einstein and an endocrinologist at Montefiore.
Dr. Barzilai's ProfileMore coverage on Dr. Barzilai
Medscape - July 14, 2020
Michal Melamed, M.D., discusses her editorial in the Clinical Journal of the American Society of Nephrology that advises nephrologists take extra precautions with their high risk patients, such as home dialysis, in light of the COVID-19 pandemic. Dr. Melamed is associate professor of medicine and of epidemiology & population health at Einstein and a nephrologist at Montefiore.
Dr. Melamed's ProfileMore coverage on Dr. Melamed
The City - July 14, 2020
Caterina Minniti, M.D., comments on the challenges faced by patients with sickle-cell disease during the COVID-19 pandemic, including the disease's side effects that may put people at higher risk for complications and death. Dr. Minniti is professor of clinical medicine and of pediatrics at Einstein and director of the Sickle Cell Center for Adults at Montefiore.
Dr. Minniti's Profile
The New York Times - June 27, 2020
A column by Nicholas Kristof hails positive examples of Hispanic community members helping one another in difficult times, including the COVID-19 pandemic. He notes that Carmen Isasi, M.D., Ph.D., who studies LatinX populations, has seen Spanish-speaking churches in New York City offering food for those in need. Dr. Isasi is associate professor of epidemiology & population health and of pediatrics.
Dr. Isasi's Profile
Modern Healthcare - June 19, 2020
Will Southern, M.D., M.S., and Shitij Arora, M.B.B.S., comment on an unpublished U.K. study that found the steroid dexamethasone helped patients with severe COVID-19, a finding consistent with their upcoming paper on steroid use in Montefiore's hospitalized patients. Dr. Southern is professor of medicine and chief of the division of hospital medicine at Einstein and Montefiore. Dr. Arora is associate professor of medicine at Einstein and an internist at Montefiore.
Additional coverage includes WIRED
Dr. Southern's ProfileMore coverage on Dr. Southern
Wired - June 17, 2020
Priya Nori, M.D., explains that the FDA's decision to revoke its Emergency Use Authorization for hydroxychloroquine to treat COVID-19 will have little impact on clinicians, many of whom had already shied away from using the antimalarial drug. Dr. Nori is assistant professor of medicine at Einstein and medical director of the antibiotic stewardship program at Montefiore Health System.
Dr. Nori's ProfileMore coverage on Dr. Nori
US News & World Report - June 16, 2020
Nir Barzilai, M.D., co-authors an op-ed that calls for a national campaign to combat chronic disease and fund research on drugs that target age-related disease—measures that could help protect vulnerable populations from the ravages of COVID-19. Dr. Barzilai is the Ingeborg and Ira Leon Rennert Chair of Aging Research and director of the Institute for Aging Research at Einstein and an endocrinologist at Montefiore.
Dr. Barzilai's ProfileMore coverage on Dr. Barzilai
WSJ - June 10, 2020
Harris Goldstein, M.D., and Brian Pelowski discuss Einstein's success in transforming a lab to provide viral transport medium after the New York City Economic Development Corporation requested the college's assistance for its initiative to produce 50,000 COVID-19 testing kits each week. Dr. Goldstein is associate dean for scientific resources and Mr. Pelowski is assistant dean for scientific operations.
Additional coverage of the initiative includes CBS NewYork, US News & World Report, NBC 4 New York, ABC7NewYork, PIX11, AMNewYork, The Staten Island Advance, Patch, Gothamist, WCBS880, The Daily News, and The New York Post.
Dr. Goldstein's ProfileMore coverage on Dr. Goldstein
March 13, 2012
New Scientist interviews Vern Schramm, Ph.D., about his research on transition state analogs, a class of drugs he has been developing that target and neutralize specific enzymes in order to combat disease. Dr. Schramm is professor and Ruth Merns Chair in Biochemistry at Einstein.
Dr.Schramm's ProfileMore coverage on Dr.Schramm
February 1, 2012
Arthritis Today interviews Dr. Anna Broder regarding her research that found continued treatment may help extend the lives of lupus patients with end-stage renal disease. Dr. Broder is assistant professor of medicine.
Dr.Broder's ProfileMore coverage on Dr.Broder
Newsweek - February 1, 2012
Microbe features research by Liise-Anne Pirofski , M.D., about a newly identified antibody that works against pneumococcal bacteria and could help to improve vaccines against pneumonia. Dr. Pirofski is chief of the division of infectious diseases at Einstein and Montefiore Medical Center and the Selma and Dr. Jacques Mitrani Professor in Biomedical Research.
Dr.Pirofski's ProfileMore coverage on Dr.Pirofski